ANTEROGEN CO., LTD. Logo

ANTEROGEN CO., LTD.

Develops and commercializes cell therapies and orphan drugs using adult stem cells.

065660 | KO

Overview

Corporate Details

ISIN(s):
KR7065660003
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로 130, 405호(가산동, 남성플라자), 서울특별시

Description

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 813.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 798.1 KB
2025-03-21 00:00
정기주주총회결과
Korean 22.9 KB
2025-03-21 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.0 KB
2025-03-13 00:00
감사보고서제출
Korean 17.8 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 1.0 MB
2025-02-26 00:00
주주총회소집공고
Korean 132.6 KB
2025-02-20 00:00
주주총회소집결의
Korean 10.3 KB
2025-02-20 00:00
주주총회집중일개최사유신고
Korean 4.9 KB
2025-02-10 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 36.4 KB
2025-01-31 00:00
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.6 KB
2025-01-31 00:00
투자판단관련주요경영사항(임상시험결과) (Wagner grade 1 당뇨병성 족부궤양 환자를 대상으로 한 ALLO-ASC…
Korean 11.4 KB
2025-01-23 00:00
주요사항보고서(유상증자결정)
Korean 25.9 KB
2024-12-09 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB

Automate Your Workflow. Get a real-time feed of all ANTEROGEN CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ANTEROGEN CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ANTEROGEN CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.